Search results
Secretary of State Antony J. Blinken Tours Antheia, Discusses the Importance of Biotechnology...
WKBN 27 Youngstown· 6 hours agoVisit demonstrates U.S. commitment to bolstering the domestic biotechnology industry and onshoring critical supply chains, including pharmaceuticals MENLO PARK, Calif. , May ...
How quantum physics could 'revolutionise everything'
BBC via Yahoo News· 4 hours agoLiam Hall's career has taken him from diesel mechanic to quantumbiotechnology [CSIRO] Growing up on a farm in Australia, Liam Hall was a mechanic...
Needham & Company LLC Reiterates Buy Rating for Vir Biotechnology (NASDAQ:VIR)
ETF DAILY NEWS· 1 day agoNeedham & Company LLC reiterated their buy rating on shares of Vir Biotechnology (NASDAQ:VIR – Free Report) in a research report report published on Friday morning, Benzinga ...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 6 hours agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
3 Biotech Stocks to Double Your Money in the Next 24 Months
InvestorPlace· 9 hours agoThe biotechnology sector is renowned for its potential to deliver groundbreaking medical treatments...
GlycoMimetics reports Phase 3 trial of uproleselan falls short By Investing.com
Investing.com· 9 hours agoGlycoMimetics, Inc. (NASDAQ:GLYC), a biotechnology firm engaged in the development of therapies for...
Adcentrx Therapeutics Announces China NMPA Grants IND Clearance for ADRX-0706, a Novel Nectin-4 ADC...
FOX 23 News Albany· 4 hours ago...China to broaden geographic representation and accelerate patient enrollment into the Phase 1a/1b studySAN DIEGO and SHANGHAI, May 6, 2024 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other...
Earnings call: Puma Biotechnology reports Q1 2024 results, NERLYNX sales dip By Investing.com
Investing.com· 3 days agoPuma Biotechnology, Inc. (NASDAQ:PBYI) discussed its first-quarter financial results for 2024,...
Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug
Market Watch· 7 hours agoVertex Pharmaceuticals posted double-digit sales growth in the first-quarter, topping Wall Street expectations, on continued growth of its drug that treats cystic fibrosis. The biotechnology ...
Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
Zacks via Yahoo Finance· 4 days agoPuma Biotechnology, Inc. PBYI reported first-quarter 2024 adjusted loss of 5 cents per share, which...